List of Treatments for Hemophilia

Novoeight (Antihemophilic factor [recombinant])

Overview
Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before, during,… read more

NovoSeven RT (Coagulation factor VIIa [recombinant])

Overview
NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, NovoSeven RT… read more

Nuwiq (Human coagulation factor VIII [rDNA], simoctocog alfa)

Overview
Nuwiq is approved by the Food and Drug Administration (FDA) to treat and prevent bleeding episodes in children and adults with hemophilia A (congenital factor VIII deficiency). The technical name of Nuwiq is… read more

Obizur (Antihemophilic factor [Recombinant], porcine sequence)

Overview
Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porcine… read more

Physical therapy

Overview
Physical therapy can help keep your joints and muscles working properly. Physical therapy can also rehabilitate joints after a bleed. Better fitness can help improve balance and strength and cut down on… read more

Profilnine (Factor IX complex [human])

Overview
Profilnine is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Profilnine is Factor IX complex (human).

Profilnine is a… read more

Proplex-T (Factor IX complex, heat treated [human])

Overview
Proplex-T is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. Proplex-T may also be used for perioperative (before, during, and after surgery)… read more

Qfitlia (Fitusiran)

Overview

Qfitlia is a medication used to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with hemophilia A or B, with or without inhibitors to factor VIII or IX. It is approved by…

Rebinyn (Coagulation factor IX [recombinant], glycoPEGylated)

Overview Rebinyn is approved by the Food and Drug Administration (FDA) to treat bleeding episodes in adults and children with hemophilia B. Rebinyn can also be used for perioperative (before, during, and after surgery)…

Recombinate (Antihemophilic factor [recombinant])

Overview
Recombinate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Recombinate can also be used for perioperative (before,… read more

ReFacto (Antihemophilic factor [recombinant])

Overview
ReFacto is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. ReFacto can also be used for perioperative (before, during, and… read more

RiaSTAP (Fibrinogen concentrate [human])

Overview
RiaSTAP is approved by the Food and Drug Administration (FDA) to treat acute bleeding episodes in people with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The technical… read more

Rixubis (Coagulation factor IX [recombinant])

Overview
Rixubis is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Rixubis can also be used for perioperative (before, during, and… read more

Roctavian (Valoctocogene roxaparvovec-rvox)

Overview
Roctavian is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with severe hemophilia A. Roctavian is also known by its drug name, valoctocogene… read more

Sevenfact (Coagulation Factor VIIa [Recombinant]-Jncw)

Overview
Sevenfact is approved by the U.S. Food and Drug Administration (FDA) for the treatment and control of bleeding episodes in adults and adolescents (12 years and older) who have hemophilia A or B with inhibitors…

Stimate (Desmopressin)

The Stimate brand name has been discontinued in the U.S. Generic alternatives may be available.

The Stimate brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview

Stimate is approved by…

Tretten (Coagulation factor XIII A-subunit [recombinant])

Overview Tretten is approved by the Food and Drug Administration (FDA) for routine prophylaxis in children and adults with congenital factor XIII A-subunit deficiency. The technical name of Tretten is Coagulation factor…

Vonvendi (von Willebrand factor [recombinant])

Overview
Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Willebrand… read more

Wilate (von Willebrand factor/Coagulation factor VIII complex [human])

Overview
Wilate is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in children and adults with von Willebrand disease. Wilate can also be used for… read more

Xyntha (Antihemophilic factor [recombinant])

Overview
Xyntha is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Xyntha can also be used for perioperative (before, during, and… read more